Tower Research Capital LLC (Trc) Amryt Pharma PLC Transaction History

Tower Research Capital LLC (Trc)

  • $5.8 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$9.63 - $12.47 $731 - $947
-76 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$10.9 - $14.29 $828 - $1,086
76 New
76 $1,000
Q4 2020

Feb 16, 2021
SELL
$12.22 - $14.16 $3,690 - $4,276
-302 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$10.8 - $13.5 $3,261 - $4,077
302 New
302 $4,000

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email